Abstract Body

Background:

Post-acute sequelae of COVID-19 (PASC) is marked by persistent or newly developing symptoms beyond 4 weeks of infection. Investigating gut integrity, oxidized lipids and inflammatory markers is important for understanding PASC pathogenesis.

Methods:

A cross-sectional study including COVID+ with PASC, COVID+ without PASC, and COVID- participants. We measured plasma markers by enzyme-linked immunosorbent assay to assess gut-barrier integrity: zonulin for intestinal permeability, lipopolysaccharide-binding protein (LBP) for microbial translocation, and fatty acid binding protein I-FABP for intestinal integrity, and to assess inflammation: high-sensitivity C-reactive protein (hsCRP) and oxidized low-density lipoprotein (Ox-LDL) assays.

Results:

415 participants were enrolled in our study. 62.17% (n=258) were COVID- and 20.48% (n=85) had PASC. COVID- participants had lower age (43.68±13.69 vs. 46.45±13.45 years; p=0.04), lower BMI (27.91±6.05 vs. 31.28±9.03; p< .0001), 39.15% (n=101) were female sex [vs. 54.14% (n=85); p=0.003], and 41.86% (n=108) were non-white race [vs. 32.48% (n=51); p=0.06] compared to COVID+. Zonulin (p< .0001), and Ox-LDL (p< .0001) were associated with COVID and PASC status. The mean Zonulin among COVID- was 3755960.41±2541177.0 ng/mL, 3912178.91±2649882.95 ng/mL among COVID+ without PASC, and the highest (5899694.16±4110456.4 ng/mL) among PASC. The mean Ox-LDL was lowest (51845.21±24328.46 U/L) among COVID-, 60530.09±26497.47 U/L among COVID+ without PASC, and 81917.21±32148.59 U/L among PASC. The estimated mean difference in Zonulin among PASC compared to COVID- was 2143734±368522 ng/mL (p< .0001) and compared to COVID+ without PASC was 1987515±471965 ng/mL (p< .0001). The estimated mean difference in Ox-LDL among PASC compared to COVID- was 30072±3311.02 U/L (p< .0001) and compared to COVID+ without PASC was 21387±4240.41 (p< .0001). Zonulin was positively associated with hs-CRP and Ox-LDL. For every unit increase in Zonulin we would expect hsCRP to increase by 86.14±15.09/100000 ng/mL (p< .0001) and OX-LDL to increase by 22.2±4.05/10000 ng/mL (p< .0001).

Conclusions:

PASC is associated with increased gut permeability, which in turn is associated with oxidized LDL and hsCRP.

Zonulin (ng/mL) and Oxidized Low-Density Lipoprotein (U/L) by COVID-19 and PASC status